Navigation Links
iCardiac Reports Significant Revenue Growth and Profitability
Date:2/23/2009

iCardiac Continues to Successfully Leverage Differentiated Service and Product Offering

Rochester, New York (PRWEB) February 23, 2009 -- iCardiac Technologies, Inc., a leading innovator in advanced cardiac safety biomakers and automated QT analysis, today announced that the company has experienced significant revenue growth as its quarter over quarter revenues have grown in excess of 100%. Pharmaceutical and biotechnology companies continue to select iCardiac as a critical provider for their cardiac safety studies because of the company's scientific expertise, project management capabilities, as well as the industry's most advanced ECG analysis methodologies, which can both dramatically reduce the cost of cardiac safety studies in addition to reducing the likelihood of false-positives. Additionally, as iCardiac's revenues have continued to increase, the company achieved profitability in the last quarter of 2008.

iCardiac continues to advance the field of cardiac safety in Phase I, II, III as well as TQT studies through its end-to-end offering of cardiac safety analysis services. During 2009, iCardiac will aggressively continue to bring to market its Highly Automated QT(sm) and QT beat-to-beat offerings.

"To date our highly automated technology has been applied in over 10 clinical QT data analyses," said Sasha Latypova, Executive Vice President at iCardiac Technologies. "Pharmaceutical companies are gaining more accurate results and are substantially lowering the cost per Thorough QT study."

The drive to greater automation of the cardiac safety analysis process stems from general dissatisfaction in the industry regarding "gold standard" manual measurements that are both time-consuming and expensive. iCardiac's highly automated QT technology is different from "fully automated" approaches - which are based solely on computers - bec
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results
2. Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008
3. CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008
4. New Study Reports Improved Patient Outcomes for Breast Cancer Patients
5. Zogenix Reports FDA Provides New PDUFA Date for Sumavel(TM) DosePro(TM)
6. Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
7. Gentiva Reports Fourth Quarter and Fiscal 2008 Results
8. Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
9. Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009
10. Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
11. YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... YORK , April 1, 2015 ... advancing protein biologic therapies and oncology supportive care ... 2014 achievements and a strategic update for 2015. ... Company has made in the areas of business ... programs, the FDA clearance of the ProctiGard product, ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 The concept ... loss, a multi-billion dollar industry. Founder of Fasciology, Ashley Black, ... an area of fat, instead of having to wait for ... Black claims that “ prior to fat cooling procedures, ... sculpting or contouring, was liposuction, which is a highly invasive ...
(Date:3/31/2015)... 31, 2015  Biotest Pharmaceuticals Corporation (BPC), a leading ... the addition of its newest plasma collection center located ... Conway, Arkansas . The over 16,000 square foot ... March 26 th 2015 and brings the total ... "This facility represents another milestone in our ...
(Date:3/31/2015)... March 31, 2015  Sonoa Health, a health tech ... has developed a world-first consumer health portal, Health&, which ... wearable devices and more. Today, the Company ... its CEO, who brings to the table more than ... has included working closely with the biggest names in ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 2PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 3PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 4PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 5PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 6Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 2Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 3Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Conway, Arkansas 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3
... , , , , , , ... Rohrer, Eppendorf AG, Germany , Lars-Erik Peters, Eppendorf 5Prime, USA , ... , The reliability of a PCR* experiment is dependent on ... for a successful , PCR is efficient sample preparation, ...
... , , , , , ... of Biology, University of California San Diego, La Jolla, , CA 92093-0349 ... , , Introduction ... colleagues , at Stanford University, makes use of a robotic ...
... , , , Multiporator , , , , , , ... Protocol No. 4308 915.040 11/2000 , , ... , , Cell line , ... Transfection with , Plasmid pEGFP-C1 (in bidistilled H 2 O), , ...
Cached Biology Technology:Efficient and Reliable PCR Setup Using Eppendorf MasterMix 2Efficient and Reliable PCR Setup Using Eppendorf MasterMix 3Efficient and Reliable PCR Setup Using Eppendorf MasterMix 4Efficient and Reliable PCR Setup Using Eppendorf MasterMix 5Efficient and Reliable PCR Setup Using Eppendorf MasterMix 6Efficient and Reliable PCR Setup Using Eppendorf MasterMix 7Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 2Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 3Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 4Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 5Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 6Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 7Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 8Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 9U-266 2
(Date:3/18/2015)... 2015 As mobile payments become more ... wallets and apps continue to be introduced into the market ... mobile payment industry in focus today are:  NXT-ID, Inc. (NASDAQ: ... BABA ), Apple Inc. (NASDAQ: AAPL ), ... (NASDAQ: FB ) NXT-ID, Inc. (NASDAQ: ...
(Date:3/12/2015)... FAIRFAX, Va. , March 12, 2015 ... company and a member of the Texas Instruments Design ... Chandrababu Naidu has demonstrated its IriShield USB MK2120U ... iris scanning facility for pension distribution. ... and assembled to be marketed in India ...
(Date:3/11/2015)... BOSTON , March 11, 2015   ... of its platform to scientifically measure and harness ... characteristics to real-time biometrics and objective measurements of ... of music at scale in large populations. It ... scientists, technologists and clinicians perform rigorous studies and ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... Hospital of Philadelphia collaborated with European gene therapy ... young children with Wiskott-Aldrich syndrome, a very rare ... Orange, M.D., Ph.D., an expert in Wiskott-Aldrich syndrome ... the study, led by German researcher Christoph Klein, ...
... Therapeutics (NYSE Amex: CXM ) reported on ... research at the American Heart Association 2010 Annual Meeting ... in Chicago, IL.  The new findings showed that coronary ... delivery to the heart, which is used in the ...
... data have suggested that omega-3 fatty acid supplements, such as ... randomized trial with more than 600 patients finds that treatment ... atrial fibrillation over six months, according to a study that ... . The study is being released early online because it ...
Cached Biology News:Children's Hospital of Philadelphia collaborates in gene therapy success in an immune disorder 2Children's Hospital of Philadelphia collaborates in gene therapy success in an immune disorder 3Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 2Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 3Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 4Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 5Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 6Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 7Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 8Use of omega-3 does not appear to reduce recurrence of atrial fibrillation 2
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Request Info...
Sprague Dawley rats, 7-8 weeks of age, mixed gender; collected by exsanguination in Alsever's solution at 1:2 dilution...
2-min, single-step add-mix-measure assay for luciferase expression and HTS in mammalian cells. Linear detection range: 2 fg to 46 ng luciferase....
Biology Products: